Effect of severe renal dysfunction on the pharmacokinetics of DNA-reactive platinum after oxaliplatin administration

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
 
Effect of severe renal dysfunction on the pharmacokinetics of DNA-reactive platinum after oxaliplatin administration

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Shunsaku
Nakagawa
Shunsaku Nakagawa nakashun@kuhp.kyoto-u.ac.jp Kyoto University Hospital Department of Clinical Pharmacology and Therapeutics Kyoto Japan *
Aimi Shimazaki nakashun@kuhp.kyoto-u.ac.jp Kyoto University Hospital Department of Clinical Pharmacology and Therapeutics Kyoto Japan -
Taro Funakoshi nakashun@kuhp.kyoto-u.ac.jp Graduate School of Medicine, Kyoto University Department of Therapeutic Oncology Kyoto Japan -
Atsushi Yonezawa nakashun@kuhp.kyoto-u.ac.jp Faculty of Pharmacy, Keio University Division of Integrative Clinical Pharmacology Tokyo Japan -
Shigeki Kataoka nakashun@kuhp.kyoto-u.ac.jp Graduate School of Medicine, Kyoto University Department of Therapeutic Oncology Kyoto Japan -
Takahiro Horimatsu nakashun@kuhp.kyoto-u.ac.jp Graduate School of Medicine, Kyoto University Department of Therapeutic Oncology Kyoto Japan -
Daiki Hira nakashun@kuhp.kyoto-u.ac.jp Kyoto University Hospital Department of Clinical Pharmacology and Therapeutics Kyoto Japan -
Kotaro Itohara nakashun@kuhp.kyoto-u.ac.jp Kobe University Hospital Department of Pharmacy Kobe Japan -
Satoshi Imai nakashun@kuhp.kyoto-u.ac.jp School of Pharmaceutical Sciences, Wakayama Medical University Department of Medical Neuropharmacology Wakayama Japan -
Takayuki Nakagawa nakashun@kuhp.kyoto-u.ac.jp School of Pharmaceutical Sciences, Wakayama Medical University Department of Clinical Pharmacology and Pharmacotherapy Wakayama Japan -
Takeshi Matsubara nakashun@kuhp.kyoto-u.ac.jp Tazuke Kofukai Medical Research Institute and Kitano Hospital Department of Nephrology Kyoto Japan -
Motoko Yanagita nakashun@kuhp.kyoto-u.ac.jp Kyoto University Graduate School of Medicine Department of Nephrology Osaka Japan -
Manabu Muto nakashun@kuhp.kyoto-u.ac.jp Graduate School of Medicine, Kyoto University Department of Therapeutic Oncology Kyoto Japan -
Kazuo Matsubara nakashun@kuhp.kyoto-u.ac.jp Wakayama Medical University School of Pharmaceutical Sciences Wakayama Japan -
Tomohiro Terada nakashun@kuhp.kyoto-u.ac.jp Kyoto University Hospital Department of Clinical Pharmacology and Therapeutics Kyoto Japan -